January 14, 2021

EDA, SCZone discuss support pharmaceutical investment

CAIRO - 13 January 2021: The Egyptian Drug Authority (EDA) and the General Authority for the Suez Canal Economic Zone (SCZone) discussed on Wednesday steps to sign a cooperation protocol to facilitate measures aiming at giving licenses to drug factories and other pharmaceutical institutions working at the zone.

In a press release, the SCZone spokesman Ali el Ghamrawy said they also discussed setting certain frameworks to specify the terms of reference, roles and commitments of every side during the implementation of the cooperation protocol.

While head of the EDA operations central department Yassin Ragaie said the two sides also agree that the investor will deal with the SCzone only concerning granting licenses.

He added that the SCZone gives priority to the manufacturing of drugs as one of the strategic industries as well as to support local market, meet the needs of citizens of Pharmaceutical products and support exporting drugs.


Categories : healthcare

Finance & Economy

PHD okays long-term joint finance from NBE

2021-01-20 07:00:00

ArabFinance: Palm Hills Developments (PHD) approved the long-term joint finance from the National Bank of Egypt (NBE) and other"...
Read More

Egypt's trade deficit dips 17% during 20...
January 20, 2021
EGX releases reminder of Orascom Constru...
January 20, 2021

Latest News


Livehealthy Festival 2021 - Focus on &ls...
January 19, 2021
Mayo Clinic Laboratories and American Ho...
January 17, 2021
EDA, SCZone discuss support pharmaceutic...
January 14, 2021